DataSheet_1_Hyperthyroidism Prevalence in China After Universal Salt Iodization.docx
收藏frontiersin.figshare.com2023-06-02 更新2025-01-22 收录
下载链接：
https://frontiersin.figshare.com/articles/dataset/DataSheet_1_Hyperthyroidism_Prevalence_in_China_After_Universal_Salt_Iodization_docx/14694456/1
下载链接
链接失效反馈官方服务：
资源简介：
BackgroundUniversal salt iodization (USI) was implemented in mainland China in 1996. The prevalence of hyperthyroidism and its risk factors now require examination.MethodsData were acquired from a nationwide Thyroid, Iodine, and Diabetes Epidemiological survey (TIDE 2015–2017) of 78,470 subjects from 31 provinces. Iodine status, and thyroid hormones and antibodies were measured. ResultsAfter two decades of USI, the prevalence of overt hyperthyroidism (OH), Graves’ disease (GD), severe subclinical hyperthyroidism (severe SCH), and mild subclinical hyperthyroidism (mild SCH) in mainland China was 0.78%, 0.53%, 0.22%, and 0.22%, respectively. OH and GD prevalence were higher in women than in men (OH: 1.16% vs. 0.64%, P
背景：我国大陆于1996年实施了普遍食盐加碘（USI）政策。如今，甲状腺功能亢进及其风险因素的普遍情况亟待审视。方法：数据来源于2015至2017年全国范围的甲状腺、碘及糖尿病流行病学调查（TIDE），共纳入31个省份的78,470名受试者。对受试者的碘营养状况、甲状腺激素和抗体进行了测量。结果：在实施USI政策二十年后，我国大陆的显性甲状腺功能亢进（OH）、格雷夫斯病（GD）、严重亚临床甲状腺功能亢进（severe SCH）和轻度亚临床甲状腺功能亢进（mild SCH）的患病率分别为0.78%、0.53%、0.22%和0.22%。OH和GD的患病率在女性中高于男性（OH：1.16% vs. 0.64%，P
提供机构：
Frontiers
